Arkolith/Insider Trading/CMPI/Form 4

venBio Global Strategic GP II, Ltd.

10% OwnerCheckmate Pharmaceuticals, Inc. (CMPI) · full profile →Form 4 · filed Apr 21, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.7M
Net Open-Market Flow
-$5.7M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 21, 2022Sell(S)62K$10.38$646K3.1M
Apr 20, 2022Sell(S)86K$10.39$889K3.2M
Apr 19, 2022Sell(S)400K$10.42$4.2M3.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-008823) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML